Do you want to read an article? Please log in or register.
Assessment of Atrial Fibrillation–Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation
Atrial Fibrillation
Related content
Atrial Fibrillation
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data
doi: 10.1161/JAHA.117.006313.
COMMENTED
Atrial Fibrillation
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
Circulation.
Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Mangat I, Khoo C, Steinberg C, Bennett MT, Tang ASL, Khairy P, CIRCA-DOSE Study Investigators.
doi: 10.1161/
Atrial Fibrillation
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial
J Am Coll Cardiol.
Poole JE, Bahnson TD, Monahan KH, Johnson G, Rostami H, Silverstein AP, Al-Khalidi HR, Rosenberg Y, Mark DB, Lee KL, Packer DL, CABANA Investigators and ECG Rhythm Core Lab.
doi: 10.1016/j.jacc.2020.04.065.
COMMENTED
Atrial Fibrillation
Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial
★ 3
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
doi: 10.1001/jama.2019.21187.
Atrial Fibrillation
Factors Predicting Arrhythmia-Related Symptoms and Health-Related Quality of Life in Patients Referred for Radiofrequency Ablation of Atrial Fibrillation: An Observational Study (the SMURF Study)
JACC: Clinical Electrophysiology.
Charitakis E, Barmano N, Walfridsson U, Walfridsson H
doi: 10.1016/j.jacep.2016.12.004.
Atrial Fibrillation
Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial
JAMA.
Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kennebäck G, Rubulis A, Malmborg H, Raatikainen P, Lönnerholm S, Höglund N, Mörtsell D
doi: 10.1001/jama.
Atrial Fibrillation
Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
Heart.
Glover BM, Hong KL, Dagres N, Arbelo E, Laroche C, Riahi S, Bertini M, Mikhaylov EN, Galvin J, Kiliszek M, Pokushalov E, Kautzner J, Calvo N, Blomström-Lundqvist C, Brugada J, ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators
doi: 10.1136/heartjnl-2018-313490.
Atrial FibrillationHeart Failure
Risk model for predicting complications in patients undergoing atrial fibrillation ablation
Heart Rhythm.
Padala SK, Gunda S, Sharma PS, Kang L, Koneru JN, Ellenbogen KA
doi: 10.1016/j.hrthm.2017.04.042.
Atrial FibrillationHeart, Artery and Coronary Diseases
Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
J Am Heart Assoc
Badoz M, Serzian G, Favoulet B, Sellal JM, De Chillou C, Hammache N, Laurent G, Mebazaa A, Ecarnot F, Bardonnet K, Seronde MF, Schiele F, Meneveau N
doi: 10.1161/JAHA.121.020917